In the context of a small cap company, working in a niche of a growth industry, Cantel has good fundamentals. It has maintained a recent growth pattern, both from organic and acquisitions. They do seem to have a good understanding of their business model. Health care, particularly of the type Cantel specializes in will continue to grow, in the U.S. and globally. Insiders own roughly 20%, which is often a measure of improving potential and commitment. I have owned CMN for over five years, purchasing it as a small cap growth vehicle for the long term. It continues to be one of my favorites.